Quantifying oxidation rates of carbon monoxide on a Pt/C electrode

The CO Tolerance of Pt/C and Pt-Ru/C Electrocatalysts in a High-Temperature Electrochemical Cell Used for Hydrogen Separation

This paper describes an experimental evaluation and comparison of Pt/C and Pt-Ru/C electrocatalysts for high-temperature (100–160 °C) electrochemical hydrogen separators, for the purpose of mitigating CO poisoning. The performances of both Pt/C and Pt-Ru/C (Pt:Ru atomic ratio 1:1) were investigated and compared under pure hydrogen and a H₂/CO gas mixture at various temperatures. The electrochemically active surface area (ECSA), determined from cyclic voltammetry, was used as the basis for a method to evaluate the performances of the two catalysts. Both CO stripping and the underpotential deposition of hydrogen were used to evaluate the electrochemical surface area. When the H₂/CO gas mixture was used, there was a complex overlap of mechanisms, and therefore CO peak could not be used to evaluate the ECSA. Hence, the hydrogen peaks that resulted after the CO was removed from the Pt surface were used to evaluate the active surface area instead of the CO peaks. Results revealed that Pt-Ru/C was more tolerant to CO, since the overlapping reaction mechanism between H₂ and CO was suppressed when Ru was introduced to the catalyst. SEM images of the catalysts before and after heat treatment indicated that particle agglomeration occurs upon exposure to high temperatures (>100 °C)

Design and synthesis of new hybrid molecules that activate the transcription factor Nrf2 and simultaneously release carbon monoxide

The transcription factor Nrf2 and its downstream target heme oxygenase-1 (HO-1) are essential protective systems against oxidative stress and inflammation. The products of HO-1 enzymatic activity, biliverdin and carbon monoxide (CO), actively contribute to this protection, suggesting that exploitation of these cellular systems may offer new therapeutic avenues in a variety of diseases. Starting from a CO-releasing compound and a chemical scaffold exhibiting electrophilic characteristics (esters of fumaric acid), we report the synthesis of hybrid molecules that simultaneously activate Nrf2 and liberate CO. These hybrid compounds, which we termed "HYCOs", release CO to myoglobin and activate the CO-sensitive fluorescent probe COP-1, while also potently inducing nuclear accumulation of Nrf2 and HO-1 expression and activity in different cell types. Thus, we provide here the first example of a new class of pharmacologically active molecules that target the HO-1 pathway by combining an Nrf2 activator coordinated to a CO-releasing group.